KIAA0368 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.4061863612701E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.89726012678193E-12 |
Normal-vs-Stage2 |
2.761100E-04 |
Normal-vs-Stage3 |
2.27689999999781E-05 |
Normal-vs-Stage4 |
1.888590E-01 |
Stage1-vs-Stage2 |
4.179000E-01 |
Stage1-vs-Stage3 |
5.495200E-01 |
Stage1-vs-Stage4 |
1.078420E-01 |
Stage2-vs-Stage3 |
8.120200E-01 |
Stage2-vs-Stage4 |
4.160200E-01 |
Stage3-vs-Stage4 |
3.132000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.15216733323587E-12 |
Normal-vs-AfricanAmerican |
1.09510000001478E-06 |
Normal-vs-Asian |
2.573600E-02 |
Caucasian-vs-AfricanAmerican |
1.980840E-01 |
Caucasian-vs-Asian |
5.009000E-01 |
AfricanAmerican-vs-Asian |
3.288600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.18713935851156E-14 |
Normal-vs-Female |
5.416300E-04 |
Male-vs-Female |
2.600500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.88110000000275E-05 |
Normal-vs-Extreme_Weight |
2.1094237467878E-15 |
Normal-vs-Obese |
5.34490000037025E-07 |
Normal-vs-Extreme_Obese |
2.15540000003678E-06 |
Normal_Weight-vs-Extreme_Weight |
6.196300E-02 |
Normal_Weight-vs-Obese |
8.173000E-01 |
Normal_Weight-vs-Extreme_Obese |
4.533800E-01 |
Extreme_Weight-vs-Obese |
7.296500E-03 |
Extreme_Weight-vs-Extreme_Obese |
7.467200E-01 |
Obese-vs-Extreme_Obese |
3.076200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.89600000000323E-05 |
Normal-vs-Age(41-60Yrs) |
1.89560001029321E-09 |
Normal-vs-Age(61-80Yrs) |
2.5113244817021E-13 |
Normal-vs-Age(81-100Yrs) |
1.17250000042368E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.595200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.092600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.274400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.143900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.024200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.120200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.68594044175552E-14 |
Normal-VS-Type2 PRCC |
4.09900000053476E-07 |
Normal-VS-KIRP CIMP |
7.240000E-01 |
Normal-VS-Unclassified PRCC |
1.51513999999686E-05 |
Type1 PRCC-VS-Type2 PRCC |
1.302590E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.804600E-04 |
Type1 PRCC-VS-Unclassified PRCC |
3.181000E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.252100E-02 |
Type2 PRCC-VS-Unclassified PRCC |
7.618000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.903580E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.48565620811314E-12 |
Normal-vs-N1 |
1.691530E-02 |
Normal-vs-N2 |
5.669400E-01 |
N0-vs-N1 |
3.416200E-03 |
N0-vs-N2 |
4.225600E-01 |
N1-vs-N2 |
9.073200E-01 |
|
|